Compile Data Set for Download or QSAR
Report error Found 108 Enz. Inhib. hit(s) with all data for entry = 13266
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772282(2-hydroxyethyl ((4-(6-((6-acetyl-8-cyclopentyl-5-m...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772331((((4-(6-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772330((((4-(6-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772332(Cyclopentyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772331((((4-(6-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772333(6-acetyl-8-cyclopentyl-2-[[5-(4-isopropylsulfonylp...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772334(6-Acetyl-8-cyclopentyl-2-((5-(4-(ethylsulfonyl)pip...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772333(6-acetyl-8-cyclopentyl-2-[[5-(4-isopropylsulfonylp...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772335(4-(6-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-d...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772334(6-Acetyl-8-cyclopentyl-2-((5-(4-(ethylsulfonyl)pip...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772291(3-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772290(2-((((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772292((S)-2-(2-amino-3-methylbutanamido)ethyl ((4-(6-((6...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772291(3-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772292((S)-2-(2-amino-3-methylbutanamido)ethyl ((4-(6-((6...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772294((R)-2-(2-aminopropanamido)ethyl ((4-(6-((6-acetyl-...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772293(2-acetamidoethyl ((4-(6-((6-acetyl-8-cyclopentyl-5...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772295((S)-2-(2-amino-4-methylpentanamido)ethyl ((4-(6-((...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772294((R)-2-(2-aminopropanamido)ethyl ((4-(6-((6-acetyl-...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772296((S)-2-(2-amino-3-hydroxypropanamido)ethyl ((4-(6-(...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772295((S)-2-(2-amino-4-methylpentanamido)ethyl ((4-(6-((...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772297((S)-2-(2-amino-4-(methylthio)butanamido)ethyl ((4-...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772296((S)-2-(2-amino-3-hydroxypropanamido)ethyl ((4-(6-(...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772298(2-(2-aminoacetamido)ethyl ((4-(6-((6-acetyl-8-cycl...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772297((S)-2-(2-amino-4-(methylthio)butanamido)ethyl ((4-...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772283((S)-4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772282(2-hydroxyethyl ((4-(6-((6-acetyl-8-cyclopentyl-5-m...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772284(tert-butyl ((4-(6-((6-acetyl-8-cyclopentyl-5-methy...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772283((S)-4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772285(4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-d...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772284(tert-butyl ((4-(6-((6-acetyl-8-cyclopentyl-5-methy...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772286((S)-N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-o...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772287((R)-6-acetyl-8-cyclopentyl-2-((5-(4-((2-(hydroxyme...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772286((S)-N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-o...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772287((R)-6-acetyl-8-cyclopentyl-2-((5-(4-((2-(hydroxyme...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772289(2-((((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772288(2-methoxyethyl ((4-(6-((6-acetyl-8-cyclopentyl-5-m...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772289(2-((((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772307(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772306(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772308((R)-N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-o...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772307(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772309(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772308((R)-N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-o...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772310(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772309(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772311(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772310(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772313(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Onquality Pharmaceuticals China

US Patent
LigandPNGBDBM772314(N-((4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7...)
Affinity DataIC50: 200nMAssay Description:A Caliper Mobility Shift assay was used to determine the inhibitory activities of a compound against CDK4/cyclin D1 and CDK6/cyclin D1 in their respe...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/4/2026
Entry Details
US Patent

Displayed 1 to 50 (of 108 total ) | Next | Last >>
Jump to: